what is the maintenance dose for semaglutide Every Other Week: Safety and FDA Guidelines Semaglutide dosing guidelines for 2026

"Some patients will end up on them for most of their lives, and thats okay," says Christine Lovato, MD, a bariatric surgeon at Banner University Medical Center in Phoenix

01/28/25 Ozempic (semaglutide) New indication January 28, 2025 - Novo Nordisk announced the FDA approval of Ozempic (semaglutide), to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD)

These preliminary studies are key to finding the drugs or interventions that can work, but we should always be mindful that they wont pan out most of the time

This is precisely the domain where in silico approaches are most mature and regulatory agencies have the most experience accepting submissions

The EMPA-KIDNEY trial enrolled a larger proportion of participants without diabetes mellitus and included individuals with lower mean eGFR (37.3 mL/min/1.73 m) and median UACR (329 mg/g) compared to DAPA-CKD